WASHINGTON - In the face of increasing momentum on Capitol Hill for confirmation of Jane Henney as the next FDA Commissioner, the Biotechnology Industry Organization's board of directors is expected this week to consider whether the organization should endorse President Clinton's nominee.

BIO President Carl Feldbaum told BioCentury that Health and Human Services Secretary Donna Shalala last week called him to solicit the organization's support for Henney.